<DOC>
	<DOC>NCT00716794</DOC>
	<brief_summary>This is a phase I/II, open-label, dose escalation study of HE3235 administered orally to patients with advanced prostate cancer who have failed hormone therapy and at least one taxane based chemotherapy regimen.</brief_summary>
	<brief_title>A Phase I/II Study of HE3235 in Patients With Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Main Patient is male and at least 18 years of age, at the time of screening; Patient has metastatic disease (any T, any N, M1); Patient has failed at least 1 taxane regimen; or Patient has symptomatic or asymptomatic CRPC and is chemotherapynaiÌˆve Patient has histologically or cytologically confirmed adenocarcinoma of the prostate; Patient has progression of disease despite adequate hormone therapy, demonstrated by one of the following: PSA level of at least 2 ng/ml that has risen on at least 2 successive occasions, at least 1 week apart. Evaluable disease progression by modified RECIST (Response Evaluation Criteria in Solid Tumors) criteria; Progression of metastatic bone disease on bone scan with &gt; 2 new lesions Patient has ECOG (Eastern Cooperative Oncology Group) performance status of 02; Main Patient has symptomatic parenchymal brain metastases or active epidural disease requiring wholebrain irradiation Treated epidural disease is allowed Patient has active infection; Patient having a history of clinically significant cardiovascular disease (such as CHF), clinically significant hepatic, respiratory or renal abnormalities; Patient who has any clinically significant abnormalities in laboratory results at screening Patient who has a history of clinically significant neurological or psychiatric condition; Additional criteria are applicable to expansion cohorts.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>HE3235</keyword>
	<keyword>Apoptone</keyword>
</DOC>